Activator of CREM in Testis and its uses
AssigneeAssociation pour le Developpement de la Recherche en Genetique Moleculaire (ADEREGEM)
InventorPaolo Sassone-Corsi
Life of this patent
Estimating the term…
Abstract
The present invention deals with a protein activation of CREM in Testis named ACT, the cDNA encoding ACT and a method to select compounds which are able to interact with ACT or its site of interaction on CREM to block or stimulate the CREM transcriptional activity in Testis. Such compounds may be useful to control male fertility.
Claims11
An activator of CREM in Testis (ACT) having the sequence:
- 1 MTSSQFDCQY CTSSLIGKKY VLKDDNLYCI SCYDRIFSNY CEQCKEPIES
- 51 DSKDLCYKNR HWHEGCFRCN KCHHSLVEKP FVAKDDRLLC TDCYSNECSS
- 101 KCFHCKRTIM PGSRKMEFKG NYWHETCFVC EHCRQPIGTK PLISKESGNY
- 151 CVPCFEKEFA HYCNFCKKVI TSGGITFRDQ IWHKECFLCS GCRKELYEEA
- 201 FMSKDDFPFC LDCYNHLYAK KCAACTKPIT GLRGAKFICF QDRQWHSECF
- 251 NCGKCSVSLV GEGFLTHNME ILCRKCGSGA DTDA
- (SEQ ID NO:
- 1) or a fragment thereof that is able to interact with CREM.
A fusion polypeptide comprising the amino acid sequence set forth in SEQ ID NO:1, or a fragment of SEQ ID NO:1, wherein said fusion polypeptide is able to interact with CREM.
An isolated polynucleotide coding for a polypeptide with the amino acid sequence set forth in SEQ ID NO:
- 1, or a fragment of SEQ ID NO:
- 1, wherein said polypeptide is able to interact with CREM.
An isolated polynucleotide comprising a polynucleotide coding for a fusion polypeptide with the amino acid sequence set forth in SEQ ID NO:1, or a fragment of SEQ ID NO:1, wherein said fusion polypeptide is able to interact with CREM.
An isolated polynucleotide encoding a fusion polypeptide comprising the nucleotide sequence set forth in SEQ ID NO:2.
An expression vector comprising a polynucleotide coding for a polypeptide with the amino acid sequence set forth in SEQ ID NO:
- 1, or a fragment of SEQ ID NO:
- 1, wherein said polypeptide is able to interact with CREM.
An expression vector comprising a polynucleotide coding for a fusion polypeptide with the amino acid sequence set forth in SEQ ID NO:1, or a fragment of SEQ ID NO:1, wherein said fusion polypeptide is able to interact with CREM.
Dependencies are inferred from the claim text.